Case Control Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Oct 6, 2019; 7(19): 2930-2941
Published online Oct 6, 2019. doi: 10.12998/wjcc.v7.i19.2930
Table 3 Relationship between expression of miR-489 and clinicopathological characteristics of melanoma
VariablenmiR-489t/FP-value
Age (yr)1.3410.185
≤ 50230.43 ± 0.26
> 50370.51 ± 0.20
Gender1.9750.063
Male300.54 ± 0.18
Female300.42 ± 0.28
Tumor size (cm)0.4390.779
≤ 2170.45 ± 0.30
> 2430.39 ± 0.16
Lesion site0.9120.366
Non-acral440.50 ± 0.22
Acral160.44 ± 0.24
TNM stage4.2690.009
I70.62 ± 0.29
II80.48 ± 0.24
III250.47 ± 0.22
IV200.31 ± 0.17
Metastasis5.622< 0.001
Yes450.30 ± 0.16
No150.64 ± 0.30